Navigation Links
Winnick Family Clinical Research Center Celebrates 6th Anniversary

Center's Innovative Research Program Continues to Draw Accolades from

Cedars-Sinai Medical Community

LOS ANGELES, March 3 /PRNewswire/ -- The Winnick Family Clinical Research Center celebrated its sixth anniversary this month and announced that it has 60 active research protocols at the Center in 2008, representing 210 clinical researchers at Cedars-Sinai Medical Center. These researchers are active in areas ranging from women's health and the genetics of common diseases to mitochondrial genetics, insulin resistance and AIDS. The Winnick Family Foundation, founded by business visionary Gary Winnick, funds the Winnick Family Clinical Research Center at Cedars-Sinai Medical Center and the critical research that takes place at its facility.

"We continue to be hugely encouraged and inspired in our research by the generous support from the Winnick Family Foundation," said Dr. Shlomo Melmed, senior vice president academic affairs of Cedars-Sinai Medical Center. "With the breakthroughs in genetic research now coming faster and gaining in practical medical relevance all the time, the generous donations made to our genetic research programs by Gary Winnick through his foundation to the Winnick Family Clinical Research Center are enabling us to explore whole new treatment protocols with the potential to improve quality of life and life expectancy for thousands of patients suffering from a wide spectrum of illnesses. We look forward to continuing our dynamic relationship with Gary and the Winnick Family Foundation for many years to come."

"It's been an honor for us to make a contribution toward the immensely important research work being carried out at Cedars-Sinai," said Gary Winnick, founder and president of the Winnick Family Foundation. "Since the beginning of our relationship with the Center, it was crucial that the innovative, exciting work being carried out with the support of the Winnick Family Foundation give special emphasis to patient-oriented research. We are confident that this is the cutting-edge of clinical research. Our hopes have been amply rewarded by the Center's groundbreaking research into some of the afflictions that are among the greatest scourges of our society. It's wonderful to see young, gifted scientists taking up the torch of pioneering research in the Human Genome era, and we can't wait to see what the 2008 Winnick Clinical Scholars and larger body of researchers at the Winnick Family Clinical Research Center will be working on over the coming year."

The Winnick Family Clinical Research Center is a fully staffed center for clinical research active in all major clinical departments, utilizing administration, nursing, and nutritional support, along with core laboratory services in sample processing, tissue culture, genome screening and bioinformatics.

SOURCE Winnick Family Clinical Research Center
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. IsoTis Receives FDA Clearance for Accell Family of Products
2. Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family
3. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
4. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
5. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
6. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
11. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Post Your Comments:
(Date:6/23/2016)... ... 2016 , ... UAS LifeSciences, one of the leading manufacturers ... Probiotics, into Target stores nationwide. The company, which has been manufacturing high quality ... list of well-respected retailers. This list includes such fine stores as Whole Foods, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. has initiated coverage on the following equities: ... (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing their ...
Breaking Biology Technology:
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):